Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.


TSX:SZLS - Post by User

Post by Str8Shuteron Mar 22, 2021 12:43pm
231 Views
Post# 32850800

Possible Buying Opportunity on Friday

Possible Buying Opportunity on FridayI have noticed a few folks on this forum referring to this Friday as some kind of deadline for a NR on the launch of Aristotle.  If the company's word is to be trusted, then the deadline should actually be next Wednesday, Mar. 31

If enough traders are somehow convinced that Q1 ends this Friday, Mar. 26, then there could be an opportunity to accumulate some cheap shares because that misunderstanding (or perhaps strategic misdirection?) may result in some Friday afternoon dumping in the absense of any news.

So, it will be good to keep some "dry powder" handy.  Planning to have a so-called "stink bid" in place, just in case that does happen.

GLTA!
<< Previous
Bullboard Posts
Next >>